Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Pre-market, Prospective, Interventional, Multi-centre Study to Evaluate Clinical Benefit, Performance, and Safety of the TI1132 Implant in an Adult Population With Sensorineural Hearing Loss

NCT07287124 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.

NCT NCT07287124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07287124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Pre-market, Prospective, Interventional, Multi-centre Study to Evaluate Clinical Benefit, Performance, and Safety of the TI1132 Implant in an Adult Population With Sensorineural Hearing Loss
Lead sponsor
Cochlear
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 3, 2026
Completion date
August 31, 2028
Enrollment
56 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, bilateral sensorineural